Dr. Tam Dinh | Cross-Cultural Leadership | Best Researcher Award

Posted on by Leadership and Management

Dr. Tam Dinh | Cross-Cultural Leadership | Best Researcher Award

University of New Mexico Health Sciences Center, United States

Author Profile

Orcid 

🎓 Early Academic Pursuits

Dr. Tam Dinh’s academic trajectory is marked by a strong foundation in science and an early dedication to medicine. He began his undergraduate studies at the University of California, Los Angeles, where he earned a Bachelor’s degree in Biochemistry in June 2017. This rigorous academic training laid the biochemical and analytical groundwork essential for his later clinical and research success. Driven by a desire to transition into medicine, he pursued a Post-Baccalaureate Premedical Certificate at the Keck Graduate Institute in California. This experience not only prepared him for medical school admission but also exposed him to the integration of science and industry, particularly during his team project collaboration with Eli Lilly.

His acceptance into the Frank H. Netter MD School of Medicine at Quinnipiac University marked a significant milestone. There, he distinguished himself both academically and through his involvement in scientific research. He graduated in May 2023 with a Doctor of Medicine, recognized with High Distinction in Basic, Translational, and Clinical Science, highlighting his deep commitment to evidence-based medicine and research innovation.

🩺 Professional Endeavors

Dr. Dinh’s clinical training reached a new height when he began his residency in Internal Medicine at the University of New Mexico in June 2023. Immersed in a diverse and underserved patient population in Albuquerque, he has not only deepened his clinical skills but also demonstrated leadership through mentorship and curriculum development. Notably, he is part of a team designing a new night float rotation curriculum, an initiative aimed at improving resident education and patient care during off-hours. He also took on a teaching role as a facilitator in the Internal Medicine Bootcamp’s Mock Paging Program, helping prepare fourth-year medical students for real-life clinical scenarios.

Through these experiences, Dr. Dinh has clearly embraced the dual roles of clinician and educator. His participation in the “Residents as Educators” seminar further emphasizes his intention to remain deeply engaged in teaching throughout his career.

🔬 Contributions and Research Focus

Dr. Dinh’s research portfolio is both diverse and clinically significant. From his early exploration of regulatory intelligence with Eli Lilly to his recent publications on rare diseases and autoimmune disorders, his work spans bench science, epidemiology, and quality improvement. His capstone research focused on the E3 ubiquitin ligase RNF31, where he explored cellular pathways using advanced molecular biology techniques. This project culminated in several poster presentations, including at the American College of Physicians (ACP) Annual Meeting.

Currently, his focus has shifted to autoimmune conditions affecting minority populations, including Statin-Associated Immune-Mediated Necrotizing Myopathy among Hispanic and Native American patients. This project, in collaboration with Dr. Wilmer Sibbitt Jr., is particularly impactful due to its attention to health disparities in underserved communities. Another ongoing quality improvement study with the New Mexico Veteran Affairs Health Care System aims to increase compliance with laboratory monitoring in patients on immunosuppressive therapy—an area of growing importance in managing chronic disease.

🏅 Accolades and Recognition

Throughout his career, Dr. Dinh has been recognized for both his academic excellence and scientific contributions. His publication in Therapeutic Innovation & Regulatory Science underscores his early commitment to improving healthcare delivery through innovation. At multiple stages of his training, he has presented research at high-level academic forums, such as the ACP and Society of Hospital Medicine meetings. His research abstracts have advanced in competitive settings, including the ACP Connecticut Chapter Scientific Meeting, attesting to the quality and relevance of his work.

Additionally, his leadership roles in student government, interest groups, and mentorship programs at Frank H. Netter School of Medicine reveal a consistent pattern of engagement and trust from his peers and faculty.

🌍 Impact and Influence

What sets Dr. Dinh apart is his unwavering focus on education, mentorship, and healthcare equity. As a peer support coach, a mentor in Internal Medicine, and an advocate for mental health among medical students, he has cultivated a culture of support and learning. His ability to balance clinical duties with academic and leadership responsibilities is a testament to his time management, emotional intelligence, and vision.

His clinical case presentations—ranging from Staphylococcus aureus bacteremia to rare congenital disorders—highlight his diagnostic acuity and commitment to lifelong learning. These contributions enhance the medical community’s understanding of complex pathologies and foster a culture of collaborative learning.

🌟 Legacy and Future Contributions

Looking ahead, Dr. Tam Dinh is poised to make lasting contributions to internal medicine, particularly in the realms of academic medicine, quality improvement, and health equity. His work in developing educational curricula, mentoring residents, and researching population-specific autoimmune diseases positions him as a future leader in academic internal medicine. His ability to straddle clinical care, teaching, and research so effectively ensures he will have a multifaceted impact.

With a growing body of peer-reviewed publications, increasing leadership in education reform, and continued commitment to underserved communities, Dr. Dinh’s trajectory suggests a future as a physician-scientist who not only treats illness but also transforms systems of care.

📝Notable Publications

Statin-associated immune-mediated necrotizing myopathy in Hispanic Americans

Author(s): Tam N. Dinh, Sharon E. Nunez, Kristin M. Gonzales, Krystle L. Tapia, Eric B. Garcia, Roderick A. Fields, Maheswari Muruganandam, N. Suzanne Emil, Frank X. O’Sullivan, Wilmer Sibbitt
Journal: Seminars in Arthritis and Rheumatism
Year: 2025

 Improving Compliance Rate of Monitoring Laboratory among Patients on Disease-Modifying Anti-Rheumatic Drugs at the New Mexico Veteran Affairs Health Care System

Author(s): Tam Dinh, Vijayalakshmi Kumar, Sharon Nunez, Micah Guess, Kimberly Reiter
Journal: Quality Improvement Poster Competition at University of New Mexico Hospital
Year: 2025

A Case Report on a Rare Disease: Phosphoglucomutase 3-Congenital Disorder of Glycosylation

Author(s): Tam Dinh, Osman Dokmeci
Journal: American College of Physicians New Mexico Chapter Meeting
Year: 2024

 Sepsis or no Sepsis, a Case of Staphylococcus aureus Bacteriuria and Bacteremia

Author(s): Tam Dinh, Riana Wurzburger
Journal: Society of Hospital Medicine New Mexico Chapter Meeting
Year: 2024

West Nile Virus Infection Complicated by Myocardial Infarction and Guillain-Barre Syndrome

Author(s): Tam Dinh, Daniel Mai, Pooja Viswanath, Ashley Keiler-Green
Journal: American College of Physicians New Mexico Chapter Meeting
Year: 2023

Mrs. Thalita Vitória Silva da Cruz | Servant Leadership | Best Researcher Award

Posted on by Leadership and Management

Mrs. Thalita Vitória Silva da Cruz | Servant Leadership | Best Researcher Award

Federal University of Pernambuco (UFPE), Brazil

Author Profile

Orchid

Early Academic Pursuits 📚🔬

Thalita Victory Silva da Cruz embarked on her academic journey at the Federal University of Pernambuco (UFPE), Brazil, where she obtained her undergraduate degree in Speech Therapy in 2017. Her passion for the field was evident early on, as she engaged in multiple academic and extracurricular activities. She served as a monitor in Fundamentals of Speech Therapy, Human Anatomy, and Voice, demonstrating her dedication to both learning and teaching.

During her undergraduate years, she actively participated in scientific research, securing a spot in the Institutional Scientific Initiation Scholarship Program (PIBIC/CNPq) from 2016 to 2017. This experience solidified her interest in investigating speech-language disorders and innovative therapeutic approaches. She was also a founding member of the Academic League of Anatomy Applied to Dentistry (LA3O) and played an active role in the Academic Directory of Speech Therapy at UFPE.

Her research inclination and commitment to community service led her to participate in multiple extension projects, including Neonatal Hearing Screening, Telephonoaudiology for Zika virus and microcephaly, and Vestibular Rehabilitation. These early endeavors laid a strong foundation for her specialization in speech-language pathology, particularly in dysphagia, orofacial motricity, and voice disorders.

Professional Endeavors 🏥🎤

After completing her undergraduate degree, Thalita pursued a Master’s in Human Communication Health (2018-2020) at UFPE, under the guidance of Zulina Souza de Lira. Her research during this period delved into Parkinson’s disease, virtual reality, and acoustic stimulation, reflecting her interest in interdisciplinary approaches to speech therapy.

Her career took a clinical turn when she worked as a Speech Therapist for the City Hall of Gravatá (2019-2020). Simultaneously, she honed her expertise in hospital-based speech therapy by completing a specialization in Orofacial Motricity with an emphasis on Hospital Speech Therapy and Dysphagia (2019-2021). This specialization enabled her to work closely with patients suffering from swallowing disorders, particularly in hospital settings.

In 2022, Thalita took on a multiprofessional residency in Family Health (RMSF) at UFPE, allowing her to work within an interdisciplinary team to provide holistic patient care. She also engaged in residency training at the Instituto de Medicina Integral Professor Fernando Figueira (IMIP), specializing in physical rehabilitation and hospital speech therapy. However, her medical residency in this area was discontinued in the same year.

In 2023, she expanded her expertise by completing a postgraduate degree in ABA (Applied Behavior Analysis) Intervention for Autism Spectrum Disorder (ASD), emphasizing her commitment to working with neurodivergent populations. She further enriched her knowledge by undertaking a postgraduate specialization in Applied Neuroscience (2024) and Music Therapy (2024), highlighting her interdisciplinary approach to speech therapy.

From 2023 to 2024, Thalita served as a substitute professor in the undergraduate Speech Therapy program at UFPE, where she taught courses in voice, orofacial motricity, dysphagia, language, and educational speech therapy. This role allowed her to share her wealth of clinical experience with future speech therapists, bridging the gap between theory and practice.

Contributions and Research Focus 🔬📖

Thalita’s research contributions are deeply rooted in speech-language pathology, neurological disorders, and rehabilitative interventions. Her Master’s research on Parkinson’s disease focused on how virtual reality and acoustic stimulation could enhance speech therapy outcomes. This innovative approach positioned her at the forefront of using technology-assisted rehabilitation in speech therapy.

She was actively involved in the Pathophysiology of the Stomatognathic System Research Group (2018-2020), where she contributed to studies on orofacial motricity, dysphagia, and related disorders. Her research interests extend to hospital-based speech therapy, multiprofessional health interventions, and neurodevelopmental disorders such as ASD.

Throughout her career, she has contributed to multiple research and extension projects, including educational speech therapy for elementary school students, neonatal hearing screening for high-risk infants, and speech rehabilitation for individuals with Parkinson’s disease. These projects highlight her commitment to improving speech-language interventions across different populations.

Accolades and Recognition 🏆🎖️

Thalita’s academic and professional journey has been marked by a series of achievements and recognitions. Her participation in scientific research, teaching, and clinical practice has earned her prestigious research grants, fellowships, and teaching positions.

She has been recognized for her contributions to interdisciplinary health interventions, particularly in hospital speech therapy and neurodevelopmental rehabilitation. Her role as a mentor and educator at UFPE further underscores her influence in shaping the next generation of speech-language pathologists.

Her leadership in academic leagues, research groups, and community health initiatives has solidified her reputation as a dedicated and influential professional in the field of speech therapy.

Impact and Influence 🌍💡

Thalita’s work has had a profound impact on speech-language therapy, hospital rehabilitation, and community health services. Her research on Parkinson’s disease and acoustic stimulation has contributed valuable insights into alternative therapeutic methods, while her clinical expertise in dysphagia and orofacial motricity has improved patient outcomes in hospital settings.

Her contributions to educational speech therapy have helped shape speech-language interventions for young students, particularly those with speech and language disorders. Her involvement in public health initiatives has played a crucial role in preventing and managing communication disorders at the community level.

Beyond her clinical and research work, Thalita’s role as an educator has been instrumental in inspiring and training new speech therapists. Her dedication to integrating technology, neuroscience, and behavior analysis into speech therapy ensures that her influence extends beyond traditional therapeutic methods.

Legacy and Future Contributions 🚀🔬

Looking ahead, Thalita Victory Silva da Cruz is poised to make even greater contributions to speech-language pathology, rehabilitation sciences, and interdisciplinary healthcare. As a Ph.D. candidate at UFPE, she continues to explore innovative approaches to communication disorders, neurorehabilitation, and hospital-based speech therapy.

Her future research is likely to delve deeper into technological applications in speech therapy, such as virtual reality, AI-driven diagnostics, and acoustic stimulation for neurodegenerative diseases. She is also expected to further expand her work on ASD interventions, educational speech therapy, and hospital-based rehabilitation.

With her strong background in applied neuroscience, behavior analysis, and music therapy, Thalita is uniquely positioned to bridge the gap between traditional speech therapy and modern rehabilitative techniques. Her legacy will be one of innovation, interdisciplinary collaboration, and a deep commitment to improving communication health for diverse populations.

As she continues to educate, research, and advocate, Thalita Victory Silva da Cruz remains a driving force in shaping the future of speech-language pathology, neurological rehabilitation, and public health interventions. 🌟

📝Notable Publications

Acoustic Parameters After Vocal Technique Associated With Virtual Reality With Electromyographic Biofeedback and Rhythmic Auditory Stimulation in Individuals With Parkinson’s Disease

Author: Thalita Victory Silva da Cruz (and co-authors)

Journal: Journal of Voice

Year: 2025

 Desempenho do diagrama de desvio fonatório no monitoramento da qualidade vocal pré e pós exercício vocal em indivíduos com Doença de Parkinson

Author: Thalita Victory Silva da Cruz (and co-authors)

Journal: CoDAS

Year: 2023

 Performance of the phonatory deviation diagram in monitoring voice quality before and after voice exercise in individuals with Parkinson’s Disease

Author: Thalita Victory Silva da Cruz (and co-authors)

Journal: CoDAS

Year: 2023

Prof. Annalisa Coliva | Philosophy | Best Researcher Award | 3647

Posted on by Leadership and Management

Prof. Annalisa Coliva | Philosophy | Best Researcher Award

University of California Irvine, United States

Author Profile

Orchid

Early Academic Pursuits 📚🎓

Annalisa Coliva embarked on her academic journey with a deep-rooted passion for philosophy, particularly in the realms of epistemology, philosophy of language, and skepticism. She earned her Master of Arts (M.A.) in Philosophy from the University of Bologna in 1996, achieving the highest distinction (110/110 cum laude), with her thesis deemed worthy of publication (dignità di stampa). Under the mentorship of Prof. E. Picardi, she honed her philosophical acumen, laying the groundwork for an illustrious career.

Determined to further her expertise, Coliva pursued advanced studies at the University of St. Andrews, UK, where she obtained an M. Litt. in Philosophy in 1997 under the guidance of the esteemed philosopher Prof. Crispin Wright. Her engagement with philosophical discourse continued as she simultaneously undertook two Ph.D. programs—one in Philosophy at St. Andrews (1997-2001) and another in Philosophy of Language at the University of Eastern Piedmont, Vercelli, Italy (1996-2001). Her dual Ph.D. trajectory reflects her dedication to rigorous academic training and her exceptional capacity for intellectual synthesis.

Professional Endeavors 🏛️💡

Coliva’s professional career commenced with several prestigious postdoctoral fellowships, beginning at the University of Bologna (2000-2002) and the University of Fribourg (2001-2003). She then secured a postdoctoral research position at the University of Modena and Reggio Emilia in 2003, which transitioned into a tenure-track assistant professorship (2005-2010). Her research and teaching focused on philosophy of language, epistemology, and skepticism, making significant contributions to contemporary philosophical discourse.

Her expertise led to an associate professorship at the same institution (2010-2016), after which she was recruited by the University of California, Irvine (UCI), where she became a full professor in 2016. She later ascended to the role of Chair of the Department of Philosophy (2017-2022), demonstrating her leadership and commitment to academic excellence. Her impact at UCI was further recognized when she was appointed Chancellor Fellow (2019-2022) and Inclusive Excellence Professor (2022-2024), solidifying her reputation as a key figure in philosophical academia.

Contributions and Research Focus 🔬📝

Coliva’s research spans various domains of philosophy, with a primary focus on skepticism, epistemology, self-knowledge, and the philosophy of language. She has engaged deeply with issues of philosophical skepticism, exploring the nature and limits of human knowledge. Her work frequently engages with Wittgensteinian philosophy, contextualism, and the epistemic significance of disagreement.

Throughout her career, she has authored and co-authored numerous influential papers, contributing significantly to the fields of epistemology and philosophy of mind. Her engagement with debates on hinge epistemology and neo-Moorean responses to skepticism has garnered widespread academic attention.

Moreover, Coliva has been instrumental in fostering interdisciplinary dialogue, particularly through her role as Co-Director of the Medical Humanities Minor at UCI. By bridging philosophy with medical ethics, she has expanded the practical applications of philosophical inquiry, influencing both theoretical and applied dimensions of the discipline.

Accolades and Recognition 🏆🎖️

Coliva’s outstanding contributions have earned her numerous qualifications and honors. She has received the National Scientific Qualification to Full Professor in Philosophy of Language in Italy (2013-2023 & 2019-2028) and the Qualification to Full Professor in France (2012-2016), alongside her earlier Associate Professorship qualifications in both countries. These accolades reflect her international recognition as a leading philosopher in her field.

Additionally, she has been invited to prestigious fellowships and visiting professorships worldwide, including at Hamburg University’s Maimonides’ Center for Advanced Studies, where she will serve as an Invited Professor in the Summer School on The Significance of Scepticism in Philosophy, Judaism, and Culture (July 2024). Such invitations underscore the global impact of her scholarship.

Impact and Influence 🌎📖

Coliva’s influence extends beyond academia into broader intellectual and cultural discussions. Her high citation count—3,184 citations on Google Scholar, an H-index of 26, and an i-10 index of 49—demonstrates her profound impact on contemporary philosophical debates.

As a mentor, she has played a crucial role in guiding graduate students and early-career scholars, fostering an environment of rigorous philosophical engagement. Her role as a DECADE Mentor at UCI highlights her dedication to diversity, equity, and inclusion in academia.

Legacy and Future Contributions 🚀🔮

Looking ahead, Coliva’s contributions to philosophy will undoubtedly continue to shape the discipline. With ongoing research, upcoming publications, and active participation in global philosophical discourse, she remains at the forefront of epistemological and philosophical inquiry. Her engagement with skepticism and self-knowledge promises further advancements in understanding human cognition and belief systems.

Her leadership in the Medical Humanities Minor program at UCI also signals an ongoing commitment to interdisciplinary work, bridging philosophy with ethical and medical concerns. As an established philosopher, mentor, and thought leader, Coliva’s legacy will inspire future generations of scholars, ensuring that her work remains a cornerstone in philosophical inquiry for years to come.

📝Notable Publications

Against Quasi-Fideism

Author: Annalisa Coliva

Journal: Religions

Year: 2025

Hysteria, Hermeneutical Injustice and Conceptual Engineering

Author: Annalisa Coliva

Journal: Social Epistemology

Year: 2025

Hinge Trust*

Author: Annalisa Coliva

Journal: Philosophy and Phenomenological Research

Year: 2025

Errors through Misidentification and the Specialness of First-Person Thought

Authors: Annalisa Coliva, Michele Palmira

Journal: Philosophical Psychology

Year: 2025

Liminal Identities and Epistemic Injustice: Introduction to the Special Issue

Authors: Anna Boncompagni, Annalisa Coliva

Journal: Social Epistemology

Year: 2024

Assoc. Prof. Dr. Angelika Kmita | Innovative Leadership | Best Researcher Award

Posted on by Leadership and Management

Assoc. Prof. Dr. Angelika Kmita | Innovative Leadership | Best Researcher Award

AGH University of Krakow, Poland

Early Academic Pursuits 🎓

Angelika Kmita’s journey into the world of materials science and nanotechnology began at AGH University of Science and Technology in Krakow, Poland. Her early academic foundation was rooted in the Faculty of Foundry Engineering, where she obtained her Master’s degree in 2008. Specializing in foundry engineering, she cultivated a deep understanding of materials processing, metal casting, and advanced metallurgical techniques. This period of her education laid the groundwork for her future research interests, particularly in nanoparticle synthesis and functional materials.

Fuelled by her passion for scientific discovery, she continued her academic endeavors at AGH University, earning a Ph.D. in Engineering in 2014. Her doctoral research likely delved into complex aspects of foundry engineering, merging traditional metallurgical principles with cutting-edge advancements in materials science. This period marked her transition from a keen student to an independent researcher, setting the stage for an illustrious career.

Professional Endeavors 🏛️

Following her Ph.D., Angelika Kmita remained at AGH University of Science and Technology, furthering her research in the interdisciplinary domain of nanotechnology. Over the years, she transitioned from a research scholar to an Associate Professor at the Academic Centre for Materials and Nanotechnology, a role she has held since April 2022.

Her professional trajectory has been deeply intertwined with material synthesis, with a special focus on ferrite nanoparticles, ferrofluids, and hydro- and aerogels. These materials hold significant potential in various applications, including biomedicine, environmental protection, and industrial manufacturing. As an academic, she has not only contributed to fundamental research but also played a pivotal role in bridging the gap between scientific inquiry and industrial application.

Apart from her research commitments, she has been actively involved in scientific and industrial projects, having participated in ten initiatives that span across different domains. This involvement underscores her commitment to innovation and the practical implementation of scientific advancements.

Contributions and Research Focus 🔬

Angelika Kmita’s research portfolio is a testament to her expertise in the field of materials science. Her work encompasses several key areas, each of which has contributed to the scientific understanding of functional materials.

She has made notable strides in the synthesis of ferrite nanoparticles, particularly focusing on controlling their morphology and size. These nanoparticles are crucial for applications ranging from magnetic storage devices to biomedical uses, such as targeted drug delivery and hyperthermia treatments.

Her research extends to ferrofluids, colloidal suspensions of magnetic nanoparticles that have broad applications in sealing, damping, and medical imaging. Additionally, she has explored hydro- and aerogels, materials known for their lightweight structure and high porosity, making them ideal for environmental applications, including water purification and pollutant absorption.

One of her groundbreaking contributions is in magnetic hyperthermia, where she examines the heating properties of aqueous nanoparticle solutions. This technique has promising applications in cancer therapy, where localized heating can selectively destroy cancer cells while minimizing damage to healthy tissue.

Her expertise also spans rheological properties of liquid phases, ensuring a better understanding of how different nanofluids behave under various conditions. Moreover, she has extensively studied thermal analysis of nanoparticles and nanocomposites, a crucial aspect in determining material stability and functionality.

Beyond fundamental research, Angelika Kmita has worked on the modification of water glass with metal oxide nanoparticles, a field that has implications for industrial applications such as coatings, adhesives, and foundry molding materials. Her work also intersects with environmental protection, particularly in addressing foundry industry-related pollution and waste management challenges.

Accolades and Recognition 🏆

Angelika Kmita’s contributions to science have been widely recognized, both within Poland and internationally. With 59 scientific publications across various countries including the USA, Germany, Croatia, and Lithuania, her work has gained significant attention in the global research community. She has also co-authored three monographs, further expanding the knowledge base in her field.

Her achievements extend beyond academic publications, as she is also a co-author of three patents, highlighting her ability to translate scientific findings into tangible innovations.

With a Web of Science h-index of 15 and nearly 500 citations, her research impact continues to grow. This metric reflects not only the breadth of her work but also its significance in advancing scientific knowledge and industrial applications.

Impact and Influence 🌍

Angelika Kmita’s research has had a profound impact on both academia and industry. Her work on nanoparticles and functional materials has influenced numerous scientific domains, from biomedical engineering to environmental sustainability. By developing novel materials and enhancing their practical applications, she has contributed to advancements in medical treatments, industrial processing, and environmental conservation.

Her involvement in industrial projects has also fostered collaborations between academia and industry, ensuring that scientific breakthroughs are effectively implemented in real-world scenarios. Through her contributions, she has helped optimize foundry processes, improve material performance, and develop sustainable solutions for various engineering challenges.

Legacy and Future Contributions 🚀

As an established researcher and academic leader, Angelika Kmita continues to push the boundaries of materials science. Her ongoing investigations into nanomaterials and their applications will likely lead to further breakthroughs in medicine, manufacturing, and sustainable engineering.

Looking ahead, her legacy will be shaped by her commitment to mentoring young scientists, fostering interdisciplinary collaborations, and pioneering innovative solutions to complex material science challenges. With the rapid evolution of nanotechnology, her expertise in ferrite nanoparticles, ferrofluids, and aerogels will remain highly relevant, driving new developments in fields ranging from energy storage to biomedicine.

Her role at AGH University of Science and Technology ensures that she will continue to influence the next generation of researchers, guiding them towards impactful scientific contributions. Through her continued work in both academia and industry, Angelika Kmita is poised to leave a lasting imprint on the fields of nanotechnology, environmental protection, and advanced material synthesis.

📝Notable Publications

Eco-Friendly Inorganic Binders: A Key Alternative for Reducing Harmful Emissions in Molding and Core-Making Technologies

Author(s): A. Kmita, Rafał S. Dańko, Mariusz Holtzer, Jarosław Jakubski, Sara Tapola
Journal: International Journal of Molecular Sciences
Year: 2024

 Aqueous Dispersion of Manganese–Zinc Ferrite Nanoparticles Protected by PEG as a T2 MRI Temperature Contrast Agent

Author(s): Dorota Lachowicz, Angelika Kmita, Marta Gajewska, Z. Jan Celinski, Janusz H. Hankiewicz
Journal: International Journal of Molecular Sciences
Year: 2023

Influence of Crystal Structure and Composition on Optical and Electronic Properties of Pyridinium-Based Bismuth Iodide Complexes

Author(s): Gisya Abdi, Marlena Gryl, Andrzej Sławek, Vijayakumar C. Nair, Konrad T. Szaciłowski
Journal: Dalton Transactions
Year: 2023

Development of Inorganic Binder Systems to Minimise Emissions in Ferrous Foundries

Author(s): Rafał S. Dańko, Angelika Kmita, Mariusz Holtzer, Dirk Lehmhus, Sara Tapola
Journal: Sustainable Materials and Technologies
Year: 2023

Aerogels Based on Cationically Modified Chitosan and Poly(vinyl alcohol) for Efficient Capturing of Viruses

Author(s): Dorota Lachowicz, Angelika Kmita, Roma Wirecka, Krzysztof Pyrc, A. Bernasik
Journal: Carbohydrate Polymers
Year: 2023

Dr. Isabel Lastres-Becker | Innovative Leadership | Best Researcher Award

Posted on by Leadership and Management

Dr. Isabel Lastres-Becker | Innovative Leadership | Best Researcher Award

Universidad Autónoma de Madrid, Spain

Author Profile

Orchid 

🌱 Early Academic Pursuits

Isabel Lastres-Becker’s academic journey began with a strong foundation in chemistry and biochemistry, which laid the groundwork for her future contributions to neurodegeneration research. She earned her Licenciatura in Chemical Sciences with a specialization in Biochemistry from the Universidad Complutense de Madrid (UCM) on June 13, 1997. Her deep interest in understanding molecular mechanisms at the intersection of biochemistry and neuroscience propelled her toward a Ph.D. with a European Mention, which she completed at UCM on March 13, 2003.

Her doctoral research focused on molecular pathways involved in neurodegenerative diseases, particularly in relation to protein misfolding, oxidative stress, and neuroinflammation. These early investigations provided her with a solid research foundation and the necessary expertise to explore groundbreaking treatments for neurological disorders such as Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), and Huntington’s disease (HD).

👩‍� Professional Endeavors

Prof. Lastres-Becker has had an illustrious career spanning over two decades, during which she has made significant contributions to understanding the molecular and cellular mechanisms of neurodegeneration. Her professional trajectory reflects a steadfast commitment to research excellence and scientific innovation.

🌐 Postdoctoral Research (2004-2009): After earning her Ph.D., she pursued postdoctoral studies at Johann Wolfgang Goethe Universität in Frankfurt, Germany (2004-2008), where she expanded her expertise in neuroinflammatory pathways and mitochondrial dysfunction. She then continued her postdoctoral research at CIBERNED, Spain (2008-2009), further strengthening her understanding of proteinopathies and neurodegenerative disease mechanisms.

🏫 Academic Positions at Universidad Autónoma de Madrid: Returning to Spain, she was awarded a Ramón y Cajal Researcher contract (2010-2015) at Universidad Autónoma de Madrid (UAM), marking a turning point in her career as she began leading independent research projects. She was later appointed Profesora Contratada Doctora (2015-2021), and subsequently, she became an Associate Professor (October 2021 – Present) at the Biochemistry Department, School of Medicine at UAM. Throughout her tenure, she has been instrumental in training future neuroscientists and has led several groundbreaking studies.

🧠 Contributions and Research Focus

Prof. Lastres-Becker’s research is highly interdisciplinary, focusing on key aspects of neurodegeneration, mitochondria, oxidative stress, and neuroinflammation. Her work has significantly advanced our understanding of disease progression and therapeutic targets.

💊 Dysregulation of the Endocannabinoid System in Huntington’s Disease: One of her major contributions is demonstrating the dysregulation of the endocannabinoid system in Huntington’s disease models. Her studies have shown how targeting cannabinoid receptors can have therapeutic benefits, opening new possibilities for pharmacological interventions.

💛 NRF2 as a Neuroprotective Factor: Her research has highlighted the protective role of the NRF2 pathway in neurodegeneration, demonstrating how modulating NRF2 activity can reduce oxidative stress and inflammation in disorders like ALS and PD.

🔄 Mitochondrial Dysfunction and Proteinopathy: Her investigations into mitochondrial dynamics, TAU pathology, and proteostasis have provided critical insights into how protein aggregation and cellular stress contribute to neurodegeneration, thereby paving the way for targeted therapies.

🏆 Accolades and Recognition

Prof. Lastres-Becker’s contributions have been widely recognized in the scientific community. She has been awarded four research sexennials, a highly prestigious acknowledgment of her continuous and impactful scientific contributions.

Her research excellence has been further demonstrated through:
🎉 Multiple research grants from national and international funding bodies.
🌟 Invitations as a keynote speaker at international neuroscience conferences.
📐 Numerous high-impact publications in peer-reviewed journals, making her work a cornerstone in neurodegeneration research.

Her studies have been extensively cited, emphasizing her global influence on the scientific understanding of neurodegenerative diseases.

🌍 Impact and Influence

Prof. Lastres-Becker’s research has had a far-reaching impact, not only within academia but also in clinical and pharmaceutical applications. Her discoveries have contributed to:

💡 Advancing drug discovery and treatment strategies for neurodegenerative diseases.
🧩 Bridging fundamental research with clinical applications, enhancing the potential for novel therapeutics.
👨‍�‍� Mentoring the next generation of neuroscientists, ensuring continued advancements in the field.

Her work continues to shape therapeutic strategies aimed at improving patient outcomes and quality of life.

🔬 Legacy and Future Contributions

As an esteemed neuroscientist, Prof. Lastres-Becker’s future contributions will likely focus on:

🚀 Developing targeted therapies for Parkinson’s, ALS, and other neurodegenerative disorders.
🎉 Exploring novel biomarkers for early diagnosis and disease progression.
🤝 Strengthening international collaborations to accelerate advancements in neurodegeneration research.
🎨 Innovating neuroprotective strategies that integrate cellular and molecular neuroscience.

Her pioneering work continues to offer hope for millions affected by neurodegenerative conditions. With a relentless pursuit of scientific discovery, her contributions will undoubtedly shape the future of neuroscience.

📝Notable Publications

Cannabinoid CB2 Receptor Modulation by the Transcription Factor NRF2 is Specific in Microglial Cells

Author: Isabel Lastres-Becker
Journal: Cellular and Molecular Neurobiology
Year: 2020

Role of MSK1 in the Induction of NF-κB by the Chemokine CX3CL1 in Microglial Cells

Author: Isabel Lastres-Becker
Journal: Cellular and Molecular Neurobiology
Year: 2019

Cx3cr1‐deficiency exacerbates alpha‐synuclein‐A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson’s disease

Author: Isabel Lastres-Becker
Journal: Glia
Year: 2018

Impaired Signaling of NF-κB and NRF2 in CX3CR1-Deficient Microglia: Implications in Tauopathies

Author: Isabel Lastres-Becker
Journal: Preprint (bioRxiv)
Year: 2018

Pharmacological targeting of GSK-3 and NRF2 provides neuroprotection in a preclinical model of tauopathy

Author: Isabel Lastres-Becker
Journal: Redox Biology
Year: 2018

Dr. Candis Morello| Innovative Leadership | Best Researcher Award

Posted on by Leadership and Management

Dr. Candis Morello| Innovative Leadership | Best Researcher Award

University of California Skaggs School of Pharmacy and Pharmaceutical Sciences, United States

Profile

Orchid 

Early Academic Pursuits 🎓

Dr. Candis M. Morello’s academic journey began at the University of California, Davis, where she earned her Bachelor’s degree in Chemistry with a minor in Socio-Cultural Anthropology (1987-1991). Her passion for patient care and pharmaceutical sciences led her to the University of California, San Francisco (UCSF), where she pursued and obtained her Doctor of Pharmacy degree (1992-1996). Following her doctorate, she further honed her clinical expertise through an ASHP-accredited Pharmacy Practice Residency with a geriatric emphasis at the Veterans Affairs San Diego Healthcare System (1996-1997).

Professional Endeavors 💊

Dr. Morello has built an illustrious career as a professor and administrator at the Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego (UCSD). Currently serving as the Associate Dean for Student Affairs and a Professor of Clinical Pharmacy (Step VI OS) in the Division of Clinical Pharmacy, she has dedicated herself to academic excellence and student mentorship. Throughout her career, she has played a significant role in shaping pharmacy education by introducing innovative curricula and fostering a culture of evidence-based practice.

Her contributions extend beyond academia into clinical practice, where she holds multiple pharmacy licenses in California (since 1996) and Nevada (since 1996). Her advanced certifications, including the Advanced Practice Pharmacist (APh) License (2018-present) and the Certified Diabetic Care and Educator Specialist (CDCES) (1999-present), have positioned her as a leader in diabetes education and patient management.

Contributions and Research Focus 🔬

Dr. Morello’s research primarily revolves around diabetes care, pharmaceutical education, and optimizing therapeutic outcomes. She has been a key advocate for integrating pharmacists into primary care teams to enhance diabetes management. Her work emphasizes patient-centered pharmaceutical care, insulin therapy education, and continuous glucose monitoring.

Beyond diabetes, her research includes innovations in pharmacy education, addressing implicit bias in healthcare, and improving interdisciplinary collaboration in patient management. Her involvement in training programs such as the UC San Diego Health Sciences Faculty Mentor Training Program and the Building a Respectful, Inclusive Culture (BRIC) NIH-supported training program reflects her commitment to fostering a more inclusive and effective healthcare environment.

Accolades and Recognition 🏆

Dr. Morello’s exemplary contributions have been widely recognized. She is a Fellow of the California Society of Health-System Pharmacists (FCSHP) and the American Society of Health-System Pharmacists (FASHP), prestigious designations that acknowledge her outstanding professional achievements and contributions to the field.

Her leadership abilities have been further honed through participation in elite programs such as the UC San Diego Faculty Leadership Academy and the Academic Leadership Training Workshop at the National Conflict Resolution Center. Additionally, she was selected for the UC San Diego National Center of Leadership in Academic Medicine (NCLAM), solidifying her reputation as a transformative leader in pharmacy education.

Impact and Influence 🌍

Dr. Morello’s impact extends to patient care, student mentorship, and professional training. She has trained countless pharmacists, shaping the next generation of healthcare professionals with a strong emphasis on evidence-based practice and patient advocacy. Her expertise in diabetes management and pharmaceutical care for chronic diseases has led to improved patient outcomes and has influenced healthcare policies at institutional and national levels.

Additionally, her work in implicit bias training and mental health advocacy has contributed to creating more inclusive, empathetic, and culturally competent pharmacy practices. Her role as an Implicit Bias Trainer at UC San Diego Health Sciences (2018-present) highlights her dedication to addressing disparities in healthcare.

Legacy and Future Contributions 🔮

Looking ahead, Dr. Morello remains committed to advancing pharmacy education, enhancing interdisciplinary healthcare collaboration, and advocating for pharmacists as essential members of healthcare teams. Her continued involvement in training programs, leadership workshops, and patient education initiatives will further solidify her legacy as a pioneer in clinical pharmacy and diabetes care.

Her latest certification in Mental Health First Aid Training (2025) underscores her dedication to addressing mental health challenges within pharmacy practice. With her unwavering passion and expertise, she is poised to continue making significant contributions to the field, shaping future pharmacists, and improving patient care standards across the nation.

📝Notable Publications

Long-Term Impact of Sustained Knowledge, Confidence, and Clinical Application Following a First-Year Student Pharmacist Diabetes Self-Care Education Program

Author: Candis M. Morello et al.
Journal: Pharmacy
Year: 2025

 Sodium-Glucose Cotransporter-2 Inhibitors versus Glucagon-Like Peptide 1 Receptor Agonists Effects on Kidney and Clinical Outcomes in Veterans with Type 2 Diabetes

Author: Candis M. Morello et al.
Journal: Kidney360
Year: 2024

Comparison between in-person, telehealth, and combination visits among veterans treated in a pharmacist-led diabetes management clinic

Author: Candis M. Morello et al.
Journal: Journal of the American Pharmacists Association
Year: 2024

Predictive Modeling of Factors Influencing Adherence to SGLT-2 Inhibitors in Ambulatory Care: Insights from Prescription Claims Data Analysis

Author: Candis M. Morello et al.
Journal: Pharmacy
Year: 2024

Improved Glycemic Control Outcomes Regardless of Mental Health Disorders in a Pharmacist-Endocrinologist Diabetes Intense Medical Management (DIMM) “Tune Up” Clinic

Author: Candis M. Morello et al.
Journal: Annals of Pharmacotherapy
Year: 2020